Extended Data Fig. 2: Characterization of immunotherapy-treated NSCLC by combined scRNA-seq and spatial transcriptomic analysis. | Nature Genetics

Extended Data Fig. 2: Characterization of immunotherapy-treated NSCLC by combined scRNA-seq and spatial transcriptomic analysis.

From: Multi-omic profiling highlights factors associated with resistance to immuno-chemotherapy in non-small-cell lung cancer

Extended Data Fig. 2

a, Dot-heat plot showing the marker genes for each T cluster. The color gradient represents the scaled expression level, and the diameter represents the percentage of cells. b, Dot-heat plot showing the marker genes for each B cluster. The color gradient represents the scaled expression level, and the diameter represents the percentage of cells. c, Dot-heat plot showing the marker genes for each Mono/Macro cluster. The color gradient represents the scaled expression level, and the diameter represents the percentage of cells. d, Dot-heat plot showing the marker genes for each CD31− stromal cluster. The color gradient represents the scaled expression level, and the diameter represents the percentage of cells. e, Dot-heat plot showing the marker genes for each DC cluster. The color gradient represents the scaled expression level, and the diameter represents the percentage of cells. f, Dot-heat plot showing the marker genes for each endothelial cluster. The color gradient represents the scaled expression level, and the diameter represents the percentage of cells. Related to Fig. 1.

Back to article page